T2 Biosystems Q1 EPS $(1.32) Misses $(1.20) Estimate, Sales $2.08M Miss $2.33M Estimate
Portfolio Pulse from Benzinga Newsdesk
T2 Biosystems reported Q1 losses of $(1.32) per share, missing the $(1.20) estimate by 10%. Sales were $2.08M, missing the $2.33M estimate by 10.82%. This is a 73.6% increase in losses and a 71.27% decrease in sales compared to the same period last year.
May 23, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
T2 Biosystems reported a 73.6% increase in Q1 losses and a 71.27% decrease in sales compared to last year, missing analyst estimates.
T2 Biosystems reported worse than expected Q1 results, with a 73.6% increase in losses and a 71.27% decrease in sales compared to the same period last year. This is likely to have a negative short-term impact on the stock price as it missed analyst estimates.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100